查看完整行情页>>

|

货币单位:美元(USD)

Chembio Diagnostics, Inc. (cemi)

实时(?):
盘后(?):
读取中...
  • -- (--%)
开盘价:-- 最高价:-- 最低价:-- 52周最高价:-- 52周最低价:--
成交量:-- 平均成交量:-- 市值:-- 市盈率:-- 预期市盈率:--
每股收益:-- 贝塔系数:-- 股息:-- 收益率:-- 总股本:--
Larry Abensur Founder of Biosynex SA, Dectra Pharm SAS and All.Diag SAS, Larry Abensur is an entrepreneur and businessperson who has been at the head of 10 different companies and holds the position of Chairman & Chief Executive Officer of Biosynex SA, Chairman for Biosynex Swiss SA, Chairman for Biosynex Premier SA and President & Director at Chembio Diagnostics, Inc. (which are all subsidiaries of Biosynex SA), Chairman for Laboratoire SBH SAS and Chairman at Gie Lab Otc. Larry Abensur is also on the board of Theradiag SA and ProciseDx LLC and Manager of ALA Financière SARL. In the past he held the position of Managing Director at PBS Orgenics, Product Manager-Human Biosynthetic Insulin at Eli Lilly & Co., Chairman at Prodiag SAS, Chairman for Dectra Pharm SAS, Chairman at Magnien SAS and Marketing Manager-France Region at The Upjohn Co. Mr. Abensur received an MBA from INSEAD and an undergraduate degree from École Nationale Supérieure de Chimie de Paris.